User:Reericks/sandbox
Clinical Success
Bispecific monoclonal antibodies have seen notable success in clinical treatments of various cancers since their introduction to the market in the 1990's and have large potential for treating other infectious diseases[1]. This success has been shown by the approval of many therapeutic antibody treatments around the world[2].
Cover letter
I'm pretty satisfied with the existing article, so I just tried to add how it's been used. I think I did it without having a slant of supporting or opposing the treatment but I also just sited a few sources that showed what it did so I think it could use a little work, I just don't know where.
 | This is a user sandbox of Reericks. You can use it for testing or practicing edits. This is not the sandbox where you should draft your assigned article for a dashboard.wikiedu.org course. To find the right sandbox for your assignment, visit your Dashboard course page and follow the Sandbox Draft link for your assigned article in the My Articles section. |
- ^ Singh, Manmohan, Manmohan (2015). Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Elsevier. pp. 164–166. ISBN 978-0-12-416603-5.
- ^ Reportlinker. "Bispecific Antibody Therapeutics Market, 2013 - 2023". www.prnewswire.com. Retrieved 2016-02-12.